Introduction {#sec0005}
============

Diabetes mellitus is a metabolic disorder characterized by the presence of chronic hyperglycemia with disturbance of carbohydrates, protein and fat metabolism. Results of insufficient secretion of insulin by pancreatic cells and/or an incomplete action of produced insulin, to which are related a serial of macrovascular and microvascular complications that affect quality of life.[@bib0485], [@bib0490], [@bib0495], [@bib0500], [@bib0505], [@bib0510], [@bib0515] It is a chronic disorder with major expansion worldwide. It is estimated that the number of diabetes sufferers increase rapidly in the coming decades due to the population ageing, poor diet, lack of physical activity and obesity.[@bib0520], [@bib0525], [@bib0530] Worldwide, in 2015, it is estimated that there were 415 million people with diabetes, and this number is expected to reach 642 million by 2040. In the same year, this disease was responsible for 5 million deaths. The World Health Organization projects diabetes as the 7^th^ leading cause of death in 2030.[@bib0525], [@bib0535] Clinical manifestation of different variants of the disease, type 2 diabetes has been suffering a major increase worldwide representing 90--95% of all cases of diabetes mellitus.[@bib0485], [@bib0525] Its prevalence increases with age,[@bib0525], [@bib0540], [@bib0545], [@bib0550], [@bib0555], [@bib0560] and is directly related to bad eating habits, abdominal and visceral obesity, sedentary lifestyles.[@bib0485], [@bib0515], [@bib0525], [@bib0560], [@bib0565], [@bib0570], [@bib0575] People with diabetes have an increased risk to have cardiovascular disease than non-diabetics, which can be 2--4 times greater.[@bib0510], [@bib0560], [@bib0580], [@bib0585], [@bib0590] Dyslipidemia and insulin resistance are risk factors for cardiovascular disease dyslipidemia and insulin resistance are risk factors for cardiovascular disease.[@bib0560], [@bib0585], [@bib0595], [@bib0600], [@bib0605], [@bib0610], [@bib0615], [@bib0620] This disease is a major cause of morbidity and reduced life expectancy in patients with diabetes.[@bib0625], [@bib0630] It is estimated that at least 68% of diabetic patients over 65 years old die from heart disease and 16% due to stroke.[@bib0635]

A balanced and healthy diet is an essential component for the prevention and selfcontrol of type 2 diabetes. It contributes to a harmonious growth and development, also reflected in the patterns of acquired diseases, that is, it has a profound impact on the individual\'s health in all its dimensions (social, physical and mental). For this, the diet must respect the nutritional recommendations, namely hours and quality of meals.[@bib0640], [@bib0645], [@bib0650] The nutrition intervention emphasizing the promotion of healthy eating has been shown to be an important point in diabetes mellitus treatment since promotes a better glycemic control and lipid profile. Diets rich in whole grains, fruits, vegetables, nuts, whit a moderate alcohol intake, a lower intake of red meat, processed refined foods, sweets, dairy products with high fat and soft drinks have been correlated with a reduced risk of diabetes, better glycemic control and lipid profile in patients with diabetes.[@bib0485], [@bib0655], [@bib0660], [@bib0665], [@bib0670], [@bib0675], [@bib0680], [@bib0685] Physical activity can be described as any body movement that which requires muscular use and more energy expenditure than at rest.[@bib0690] Is widely recommended as an essential non-pharmacological therapeutic strategy to the prevention and metabolic control of type 2 diabetes.[@bib0485], [@bib0525], [@bib0685]

International organizations recommend a weekly accumulation of a minimum of 150 min of aerobic moderate exercise (50--70% the maximum heart rate), 75 min of vigorous intensity, or a combination of both types, distributed over a minimum of 3 days per week, with no more than 2 consecutive days without exercise.[@bib0485], [@bib0695]

The objective of this systematic review is evaluate the effectiveness of the implementation of independently or combined dietary and physical activity programs on the blood glucose values and lipid profile in patients with type 2 diabetes, including participants aged 60 and more years. Given the high aging rate and the prevalence of type 2 diabetes of the population, we choose to conduct an analysis of several publications on this topic.

Methods {#sec0010}
=======

Data sources {#sec0015}
------------

A comprehensive search was performed in the international scientific database:

PubMed/Medline, using the descriptors "Diabetes AND ((food habits) OR BMI OR obesity OR (physical activity) OR exercise OR glucose OR HbA1c OR (total cholesterol) OR HDL OR LDL OR VLDL OR triglycerides OR apoA OR apoB OR apoC OR apoD OR apoE)".

Study selection, selection criteria and quality assessment {#sec0020}
----------------------------------------------------------

The research and study selection was performed independently by two reviewers. If there were uncertainty regarding eligibility, their inclusion or not was jointly decided by the four reviewers. Were considered eligible for the purposes of this review only randomized clinical trials comparing physical activity or dietary interventions with control group in type 2 diabetes, that include participants with 60 and more years, published between 2010 and 2015, available in full text, with evaluation of the proposed intervention and published in Portuguese, Spanish, English or French. Were excluded studies that did not recruit elderly patients with type 2 diabetes, opinion articles, and with no final assessment of the proposed intervention. The following PICO (Population, Intervention, Comparator, Outcome) methodology was used: Population: patients with type 2 diabetes, age ≥60 years; Implementation/Indicator: Dietary program and physical activity; Comparator: control program; Outcome: Impact on the blood glucose values and lipid profile in patients with type 2 diabetes.

The included articles were assessed for the risk of bias using the recommendations for judging the risk of bias, provided in Chapter 8 of the Cochrane Handbook,[@bib0700] since the selected studies were randomized. Such studies are very prone to bias due to the arbitrariness of researchers in sample selection, assessment of the variables analyzed and difficulty in control of external variables that can influence the results.[@bib0705]

The evaluation consists of two parts, where the risk of bias is assessed in seven areas: Random sequence generation, allocation concealment, blinding of participants and researchers, blinding of outcome assessment, incomplete outcome data, selective reporting and other sources of bias. The first makes an analysis to what is described in that study and analyzed in order to be able to classify the risk of bias. In the second part is made the classification of the risk of bias in one of three categories: low risk of bias, high risk of bias or uncertain risk of bias, for each of the analyzed domains.[@bib0700] The general description and an overall assessment of risk of bias of the included trials in this review are shown in [Table 1](#tbl0005){ref-type="table"} and [Figure 1](#fig0010){ref-type="fig"}.Table 1Risk of bias for each study included in the analysis.Table 1Random sequence generation (selection bias)Allocation concealment (selection bias)Blinding of participants and researchers (performance bias)Blinding of outcome assessment (detection bias)Incomplete outcome data (attrition bias)Selective reporting (reporting bias)Other biasGavin et al. (2010)[@bib0755]![](fx1.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Okada et al. (2010)[@bib0710]![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Church et al. (2010)[@bib0715]![](fx1.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Wong et al. (2010)[@bib0805]![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)De Greef et al. (2011)[@bib0785]![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Ariza Copado et al. (2011)[@bib0790]![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Jorge et al. (2011)[@bib0720]![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Larose et al. (2011)[@bib0725]![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Ferrer-García et al. (2011)[@bib0565]![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Cohen and Johnston (2011)[@bib0665]![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Sharma et al. (2011)[@bib0845]![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Kahleova et al. (2011)[@bib0815]![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Andrews et al. (2011)[@bib0825]![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Balducci et al. (2012)[@bib0730]![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Balducci et al. (2012)[@bib0735]![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Swift et al. (2012)[@bib0750]![](fx3.gif)![](fx3.gif)![](fx2.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Soric (et al. 2012)[@bib0855]![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Breslavsky et al. (2013)[@bib0870]![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Strobel et al. (2014)[@bib0860]![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Kampmann et al. (2014)[@bib0865]![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Ryu et al. (2014)[@bib0875]![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Yuan et al. (2014)[@bib0795]![](fx3.gif)![](fx1.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Asemi et al. (2014)[@bib0945]![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Li et al. (2014)[@bib0840]![](fx3.gif)![](fx3.gif)![](fx2.gif)![](fx2.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Stenvers et al. (2014)[@bib0830]![](fx1.gif)![](fx1.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Vinetti et al. (2015)[@bib0740]![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Motahari-Tabari et al. (2015)[@bib0745]![](fx1.gif)![](fx3.gif)![](fx3.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Ostadrahimi et al. (2015)[@bib0950]![](fx1.gif)![](fx3.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Hove et al. (2015)[@bib0955]![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)Tonucci et al. (2015)[@bib0960]![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)![](fx1.gif)[^1]Figure 1Percentage of risk of bias for each study included in the analysis.

In [Table 2](#tbl0010){ref-type="table"}, are reported the general description of the included trials in this review per intervention and continent. In this table, taking into account the type of intervention, the articles were grouped in six categories: physical activity; dietary program; physical activity and dietary program; educational sessions; educational sessions whit physical activity; and educational sessions, physical activity and dietary program. Each study has the year and place of development, number of participants, description of the intervention, its duration and the principal resultsTable 2General description of the included trials in this review per intervention and continent.Table 2Physical activity: American continentAuthor ReferenceYear, CountryGroup, number of patientsDescription of interventionLength of programResultsGavin et al.[@bib0755]2010, CanadaAerobic training group, 60Aerobic training supervised, three times per week on a treadmill or cycle ergometer.6 monthsTriglycerides (TG) were reduced in resistance combined and aerobic exercise group, *p* = 0.02/0.001/*p* \> 0.05. Apo B48 decreased in resistance and combined exercise group, *p* \< 0.05/*p* \> 0.05. In the aerobic exercise group increased, *p* \> 0.05.Resistance exercise, 642--3 sets the resistance exercise supervised on weight machines, 2--3 days per weekCombined exercise, 64Full aerobic plus the full resistance program.Control, 63Revert to their level of activity at baseline and to maintain this levelChurch et al.[@bib0715]2010, USAAerobic exercise, 72Aerobic exercise supervised at 50%--80% of maximum oxygen consumption with an energy expenditure of 12 kcal/kg per week9 monthsCompared with the control group, the HbA1c decrease 0.34% in the combined exercise group, 0.16% in resistance exercise group, and 0.24% in aerobic exercise group, *p* = 0.03/032/0.14.\
In diabetes patients with HbA1c ≥ 7 and compared with the control group, the combined exercise reduces HbA1c 0.53%, the aerobic exercise 0.50%, and 0.33% the resistance exercise, *p* = 0.008/0.01/0.10.Resistance exercise, 73Resistance exercise supervised 3 days per weekCombination exercise, 762 resistance training sessions per week and aerobic exercise supervised with energy expenditure of 10 kcal/kg per weekControl, 41Stretching and relaxation classes supervised. And was asked to maintain current activity during the study periodJorge et al.[@bib0720]2011, BrazilAerobic, 1260 min of aerobic exercise (cycling) 3 days per week12 weeksIt has been found in 4 groups a reduction of fasting and postprandial glucose, *p* \< 0.05.\
The HbA1c and insulin resistance decreased in the aerobic, resistance and combined exercise group and increased in the control group, *p* \> 0.05.\
It was found in 4 groups decrease the TC and TG, *p* \< 0.05.\
The HDL cholesterol had a decreased in the aerobic, resistance and control group, *p* \< 0.05.Resistance, 1260 min of resistance exercise supervised 3 days per weekCombined, 12Aerobic and resistance exercise interchanged at the same intensity and half the volume of the aerobic and resistance groupControl, 12Stretching exercises designed to provide participative involvement but not to elicit changes in muscle strength or cardiovascular fitnessLarose et al.[@bib0725]2011, CanadaAerobic, 6045 min of aerobic exercise supervised (treadmill or cycle ergometer) 3 days per week6 monthsAerobic exercise and resistance reduced HbA1c (0.51/0.38%, *p* = 0.007/0.037) compared with the control group.\
In the group that practiced exercise combined the reduction was 0.46%, *p* = 0.014 compared to the group that practiced aerobic exercise and 0.59%, *p* = 0.001 compared to the group that performed resistance exercise.Resistance, 6445 min of resistance exercise supervised on weight machines, 2--3 days per weekCombined, 64Aerobic and resistance exercise supervisedControl, 63Subsequent to the run-in phase, were asked to revert to their level of activity at baseline and to maintain this level for the remainder of the studySwift et al.[@bib0750]2012, USAAerobic exercise, 50Aerobic training supervised by study staff in exercise training laboratory.9 monthsThere was a reduction in HbA1c from the group practiced combined exercise (0.34%, *p* \< 0.05) compared with the control group (+0.24%). In the group aerobic exercise and resistance is also reduced (0.15/0.16%, *p* \> 0.05). The increased fasting glucose in the 4 groups (aerobic exercise: 2.96 mg/dl; resistance: 4.76 mg/dl; combined: 0.46 mg/dl; control: 7.54 mg/dl) and fasting insulin decreased (aerobic exercise: 1.53 pmol/l resistance: 1.89 pmol/l; combined: 2.05 pmol/l; Control: 3.61 pmol/l, *p* \> 0.05).Resistance exercise, 58Resistance training supervised in exercise training laboratory 3 days per weekCombination exercise, 59Combination of resistance and aerobic training in exercise training laboratory.Control, 37Stretching and relaxation classes and was asked to maintain their current activity during the study period.Physical activity: Asiatic continentAuthor referenceYear, countryGroup, number of patientsDescription of interventionLength of programResultsOkada et al.[@bib0710]2010, JapanExercise, 21Aerobic and resistance exercise program from 3 to 5 days per week, supervised by physiotherapist.3 monthsThe HbA1c was decreased in the exercise and control group, *p* \< 0.01. Fasting blood glucose levels in plasma in the exercise group increased and decreased in the control group, *p* \> 0.05. There was a decreased in both group the TC, *p* \> 0.05, LDL cholesterol (exercise: *p* \< 0.01; control: *p* \< 0.05) and TG, *p* \> 0.05. The HDL cholesterol increased (exercise: *p* \< 0.01; control: *p* \< 0.05)Control, 17Without exercise trainingMotahari-Tabari et al.[@bib0745]2015, IranExercise, 27Aerobic exercise 3 times a week8 weeksThe fasting glucose was reduced in the exercise group and increased in the control group, *p* = 0.06. These changes were not statistically significant between groups, *p* = 0.06. Plasma insulin was reduced in both groups throughout the study *p* = 0.002. These changes were statistically significant between groups, *p* = 0.007. Insulin resistance was lower in the exercise group compared with the control group. These changes were statistically significant throughout the study and between groups, *p* = 0.004/0.007Control, 26Without exercise trainingPhysical activity: European continentAuthor referenceYear, countryGroup, number of patientsDescription of interventionLength of programResultsFerrer-García et al.[@bib0565]2011, SpainIntervention, 4445 min of combined physical exercise program (aerobic and anaerobic exercises) from 3 to 5 days per week, and conventional treatment for diabetes24 weeksHbA1c decreased in the experimental and control group, *p* \< 0.05. The fasting glucose decreased in the intervention group, *p* = 0.002, and increased in the control group, *p* = 0.10. In the experimental group TG, TC and LDL decreased and HDL increased after 6 months (*p* = 0.138/0.046/0.217/0.226). In the control group TC, LDL and HDL were reduced and increased TG (*p* = 0.624/0.220/0.460/0.032).Control, 40Conventional treatment for diabetesBalducci et al.[@bib0730]2012, ItalyExercise moderate-to-high intensity (HI), 152Aerobic and resistance exercise supervised the moderate to high intensity 2 days per week and recommendations on both types of exercise every 3 months12 monthsThere were lower HbA1c, fasting blood glucose, plasma insulin, insulin resistance in the LI group (*p* = 0.005/0.030/0.009) and the HI group (*p* \< 0.001/=0.003/=0.03/=0.003). In the LI group, TG and HDL cholesterol increased (*p* = 0.010/\<0.001), the TC and LDL cholesterol decreased (*p* \< 0.001).\
In the HI group, there was a decrease of TG, TC and LDL, the HDL cholesterol increased (*p* = 0.51/\<0.001/\<0.001/\<0.001).Exercise low-to-moderate intensity (LI), 136Aerobic and resistance exercise supervised the low to moderate intensity 2 days per week and recommendations on both types of exercise every 3 monthsControl, 303Exercise counselingBalducci et al.[@bib0735]2012, ItalyExercise group, 3675 min day of aerobic and resistance exercise supervised twice weekly. All participants received structured exercise counseling, encouraging any type of leisure-time physical activity12 monthsIn the exercise group there were lower HbA1c, TC, and LDL cholesterol (*p* \< 0.001/=0.20/=0.04). TG and HDL cholesterol increased (*p* = 0.80/0.25). In the control group HbA1c, TC, HDL and LDL cholesterol decreased (*p* = 0.16/0.74/0.18/0.75) and increased TG (*p* = 0.035).Control group, 34Structured exercise counseling, encouraging any type of leisure-time physical activityVinetti et al.[@bib0740]2015, ItalyIntervention, 10Aerobic, resistance and flexibility exercise supervised by personal trainers and hospital-based setting12 monthsThe fasting plasma glucose decreased in intervention/control groups (*p* = 0.32/0.26). HbA1c decreased in the experimental group and increased in the control group (*p* = 0.08/0.25,these changes were not statistically significant between groups, *p* = 0.75/0.05). The same is observed with the fasting insulin (*p* = 0.01/0.42, these alterations were statistically significant between groups, *p* = 0.02), insulin resistance (*p* = 0.02/*p* \< 0.05), TC (*p* = 0.03/0.52, these changes were not statistically significant between groups, *p* = 0.05), LDL cholesterol (*p* = 0.04/\>0.05) and TG (*p* = 0.11/0.33. These changes were statistically significant between groups, *p* = 0.06). HDL cholesterol decreased in the 2 groups (*p* = 0.79/0.20). This reduction was not statistically significant between the groups *p* = 0.29.Control, 10Standard medical care onlyDietary program: American continentAuthor referenceYear, countryGroup, number of patientsDescription of interventionLength of programResultsCohen and Johnston.[@bib0665]2011, USAAlmond, 728 g almond ingestion 5 day/week12 weeksThe consumption of almond decreased the HbA1c, *p* = 0.045, glucose concentration, *p* = 0.305 and TG, *p* \> 0.05.\
The fasting insulin increased in groups 2, *p* = 0.610.\
The TC and LDL increased consumption almond group and decreased in the control group, *p* \> 0.05.Control, 62 cheese sticks ingestion 5 day/weekSoric et al.[@bib0855]2012, USAVitamin D, 192000 IU vitamin D3 (cholecalciferol) daily by mouth12 weeksThe HbA1c decreased in Vitamin D group and increased in control group, *p* = 0.16. In the subgroup analysis, diabetic patients with baseline HbA1c \> 9% who had received vitamin D, have a largest decline in HbA1c (−1.4%, *p* = 0.013) compared to those with values between 8 and 8.9% (+0.3, *p* = 0.90) and between 7 and 7.9% (+0.1%, *p* = 0.50).Vitamin C (control), 18500 mg vitamin C daily by mouth.Toinucci et al.[@bib0960]2015, BrazilProbiotic, 23120 g/daily of fermented milk fermented milk containing *Lactobacillus acidophilus La-5* and *Bifidobacterium animalis subsp lactis BB-12*6 weeksHbA1c decreased in the probiotic group and increased in the placebo group, *p* = 0.06/0.82. These changes were statistically significant between groups *p* = 0.02. The fasting glucose increased in 2 groups *p* = 0.14/0.65, no statistically significant differences between groups, *p* = 0.48. The same is observed with insulin resistance, *p* = 0.41/0.7; between groups: *p* = 0.77, and TG, *p* = 0.16/0.08, between groups: *p* = 0.62.\
Insulin decreased in the 2 groups, *p* = 0.73/0.95, no statistically significant differences between groups, *p* = 0.72.\
The TC, LDL and HDL cholesterol were reduced in the probiotic *p* = 0.52; *p* = 0.31; *p* = 0.50, and increased in the placebo group, *p* = 0.01, *p* = 0.004; *p* = 0.59. These changes were statistically significant differences between groups for the TC/LDL values, *p* = 0.04/0.03, but not HDL cholesterol, *p* = 0.38.Placebo, 22Conventional fermented milk.Dietary program: Asian continentAuthor referenceYear, CountryGroup, number of patientsDescription of interventionLength of programResultsWong et al.[@bib0805]2010, ChinaFish oil, 49Fish-oil (4 g/day) supplements12 weeksThe consumption of fish oil reduced the serum TG, *p* \< 0.01, TC, *p* = 0.08, LDL cholesterol, *p* = 0.53, HDL cholesterol, *p* = 0.65 and fasting glucose, *p* = 0.08.Control, 48Olive-oil, with equivalent calories of fish-oil supplementsSharma et al.[@bib0845]2011, IndiaExperimental, 209 g brewer\'s yeast (42 μg chromium) daily. 3 capsules after breakfast, lunch and dinner with either milk or water3 monthsThere was a reduction in the experimental group/control in the HbA1c, *p* \< 0.001/\<0.01, TC, *p* \< 0.02/\<0.08, LDL cholesterol, *p* \< 0.001/\<0.04 and VLDL cholesterol, *p* \< 0.04/\<0.02. The TG decreased in the experimental group and increased in the control group, *p* \< 0.05/\<0.09. HDL cholesterol increased in the experimental group, and decreased in the control group, *p* \< 0.5/\<0.06.Control, 20Received yeast devoid of chromiumBreslavsky et al.[@bib0870]2013, IsraelGroup 1, 24Oral daily supplementation with vitamin D (1000 U/day)12 monthsIn group 1, fasting glucose, HbA1c, insulin, and insulin resistance increased, *p* \> 0.05. The same was found with TC, HDL and LDL cholesterol, *p* \> 0.05. Only the TG decreased, *p* \> 0.05. In group 2 only registered lower HbA1c, *p* \> 0.05. The fasting glucose, insulin, insulin resistance, TC, HDL cholesterol, LDL cholesterol and TG increased, *p* \> 0.05.Group 2 (control), 23Placebo capsulesRyu et al.[@bib0875]2014, KoreaVitamin D, 40Cholecalciferol 2000 IU/day and calcium 200 mg/day24 weeksHbA1c, insulin resistance and TG increased in the vitamin D group and decreased in placebo group, *p* = 0.280/0.981/0.682.\
The fasting blood glucose increased 3.2 ± 27.5 mg/dl in vitamin D group and 28.2 ± 3.9 mg/dl in the placebo group, *p* = 0.891.\
The CT, LDL and HDL cholesterol increased in the vitamin D group and in the placebo group, *p* = 0.248/0.092/0.998.Placebo, 41Calcium 200 mg/dayAsemi et al.[@bib0945]2014, IranSynbiotic food, 3127 × 10^7^ UFC *L. sporogenes* and 1.08 g inulin each day.6 weeksThe consumption of probiotic compared with the control resulted in a decrease in serum insulin levels, *p* = 0.03. The fasting plasma glucose also decreased in the probiotic group and increased in the control group. The same is observed with insulin resistance. The serum levels of TG, TC and LDL cholesterol increased in 2 groups. The HDL cholesterol increased in the group that consumed probiotic, and decreased in the control group. All these changes were not statistically significant, *p* \> 0.05.Control food, 31Same substance without probiotic bacteria and insulinLi et al.[@bib0840]2014, ChinaBreakfast replacement, 3675 g of the low glycemic index multi-nutrient supplement (provides 346 kcal energy) in place of breakfast12 weeksIn breakfast replacement group showed a decrease in HbA1c, glycated protein in the serum, *p* \< 0.01 and insulin, *p* \> 0.05. The fasting glucose and insulin resistance increase, *p* \> 0.05. In the control group there was an increase in fasting blood glucose, HbA1c, insulin resistance, *p* \< 0.05 and insulin, *p* \> 0.05. Glycated serum protein decreased, *p* \< 0.05. In the breakfast replacement group TG, TC, HDL cholesterol, Apo A1 and Apo B increased, *p* \> 0.05. In the control group there was a decrease of TG, TC and LDL cholesterol, *p* \< 0.05) and increased HDL-cholesterol, Apo A1, *p* \> 0.05 and Apo B, *p* \< 0.005.Control, 18Healthy breakfastOstadrahimi et al.[@bib0950]2015, IranIntervention, 30600 ml fermented milk (kefir) containing probiotics twice a day (in lunch and dinner)8 weeksThere was a decrease in serum glucose in both groups (intervention: *p* = 0.05; placebo: *p* \> 0.05, this decrease was statistically significant between groups, *p* = 0.03. HbA1c decreased in the intervention group and increased placebo group, *p* = 0.001/*p* \> 0.05, these changes were statistically significant between groups, *p* = 0.02. The TC, LDL cholesterol and TG levels decreased in both, *p* \> 0.05. The HDL cholesterol decreased in the intervention group and increased in the placebo group, *p* \> 0.05.Placebo, 30600 ml conventional fermented milk (dough) twice a day (in lunch and dinner)Dietary program: European continentAuthor referenceYear, countryGroup, number of patientsDescription of interventionLength of programResultsStrobel et al.[@bib0860]2014, GermanyVerum, 4020 drops vigantol oil once a week, corresponding to a daily dose of 1904 IU/day6 monthsThe fasting glucose and HbA1c decreased in the 2 groups (verum, *p* = 0.282/0.245; control: *p* = 0.85/0.064). Insulin increased in the 2 groups, *p* = 0.492/0.013. The decreased insulin resistance in verum group and increasing in the control group, *p* = 0.954/0.030. The HbA1c value was lowest at baseline and after intervention in diabetic patients with levels of 25-hydroxy-vitamin D \> 20 ng/ml, *p* = 0.008/0.009.Placebo, 40Placebo oil consisting of medium chain triglyceridesKampmann et al.[@bib0865]2014, DenmarkVitamin D, 7Colecalciferol (280 μg daily for 2 weeks, 140 μg daily for 10 weeks)12 weekHbA1c decreased in vitamin D group, and placebo group, *p* = 0.79/0.07. Glucose increased in 2 groups, *p* = 0.78/0.73; none of these changes was statistically significant between groups, *p* = 0.13/0.89. Insulin in serum increased in the vitamin D group and decreased in the placebo group, *p* = 0.087/0.95, and insulin secretion increased in the 2 groups, *p* = 0.22/0.25. None of these changes was statistically significant between groups, *p* = 0.28/0.34. The TC (*p* = 0.90/0.61) and LDL (*p* = 1.00/0.16) increased in vitamin D and placebo group, and HDL decreased in the 2 groups, *p* = 0.65/0.92. None of these changes was statistically significant between groups, *p* = 0.71/0.28/0.78.Placebo, 8Identical placebo tabletsStenvers et al.[@bib0830]2014, NederlandsLow glycaemic response (GR), 9103 ml of Glucerna SR3 monthsIn the low glycaemic response group there was a decrease in fasting glucose, TC, LDL and HDL cholesterol. Fasting insulin increase, and HbA1c was maintained.\
In the control group increased fasting glucose, HbA1c, fasting insulin, LDL and HDL cholesterol, and decreased TC. None of these changes was statistically significant, *p* \> 0.05.Control, 11Free-choice breakfastHove et al.[@bib0955]2015, DenmarkCardi04 yogurt, 23300 ml milk fermented with *L. helveticus* (Cardi04 yogurt)12 weeksHbA1c increased in the Cardi04 yogurt group and placebo group, *p* = 0.740. Compared to placebo group, the plasma glucose and insulin resistance decreased in the Cardi04 yogurt group, *p* = 0.525/0.022. The C-peptide, insulin, CT and LDL cholesterol increased, *p* = 0.616/0.628/0.835/0.851. HDL cholesterol and proinsulin decreased, *p* = 0.092/0.035. The TG showed the same value. In the control group, TC, LDL, HDL, TG and proinsulin increased. The C-peptide and insulin decreased, *p* \< 0.05.Placebo, 18300 ml artificially acidified milk (placebo yogurt)Physical activity and dietary program: European continentKahleova et al.[@bib0815]2011, Czech RepublicExperimental, 3712 weeks of vegetarian diet. The second 12 weeks of the diet were combined with aerobic exercise.24 weeksThe HbA1c and fasting glucose were reduced in the experimental group to 3/6 months, *p* \< 0.001. In control group HbA1c decreased to 3/6 months, *p* \< 0.001/*p* = 0, 370. The fasting plasma glucose decreased to 3/6 months, *p* \< 0.01/*p* = 0.420. The fasting plasma insulin decreased at 3/6 months in the experimental group, *p* \< 0.05/0.001 and experimental group, *p* = 0.780.\
In experimental group to 3/6 months decreased the TC, TG, LDL and HDL cholesterol, *p* = 0.730/*p* = 0.120/*p* \< 0.05/*p* = 0.070.\
In the control group at 3 months increased TC and decreased at 6 months, *p* = 0.730. HDL cholesterol increased, *p* = 0.70/*p* \< 0.05, LDL cholesterol was reduced, *p* = 0.050 and increased TG, *p* = 0.12.Control, 3712 weeks of conventional diabetic diet. The second 12 weeks of the diet were combined with aerobic exerciseAndrews et al.[@bib0825]2011, EnglandDietary Intervention, 248Intensive diet intervention to lose 5--10% of their initial bodyweight and to maintain this loss throughout the study. Plus dietary consultation every 3 months with monthly nurse support.12 mothsCompared with the control group, HbA1c decreased in dietary intervention group and physical activity and dietary intervention group, *p* = 0.005/0.027. The same is observed with glucose, *p* \< 0.0001/*p* = 0.01, and fasting insulin, *p* = 0.001/0.022.\
Insulin resistance decreased in the diet intervention group and dietary intervention and physical activity, *p* = 0.0001/0.011. The insulin secretion decreased in the dietary intervention group diet and dietary intervention and physical activity group, *p* \> 0.05.\
The TC decreased in the dietary intervention group and dietary intervention and physical activity, *p* \> 0.05. The LDL and HDL cholesterol decreased in the dietary intervention group and increased in dietary intervention and physical activity group. TG increased in the dietary group and decreased in dietary intervention and physical activity group, *p* \> 0.05.Dietary intervention and physical activity, 246Intensive diet intervention plus a pedometer-based physical activity program.Control, 99Initial dietary consultation and follow-up every 6 monthsEducational sessions: European continentAuthor referenceYear, countryGroup, number of patientsDescription of interventionLength of programResultsDe Greef et al.[@bib0785]2011, BelgiumIndividual consultation, 22Physical activity individual counseling by a general practitioner12 weeksThe participants of individual, counseling/group and control group had a decrease in HbA1c value, *p* ≤ 0.05. The fasting glucose also decreased, *p* \< 0.05, and increased in the control group, *p* \> 0.05. The TC increased in the 3 groups, *p* \> 0.05.Group counseling, 21Physical activity group counseling by a general practitionerControl, 24General care from their general practitionerEducational sessions and physical activity European continentAuthor referenceYear, countryGroup, number of patientsDescription of interventionLength of programResultsAriza Copado et al.[@bib0790]2011, Spain1: diabetes education, 27Educational sessions with basic content on diabetes mellitus6 monthsCompared with the control group, HbA1c decreased in 3 groups (Group 1: −1.00; Group 2: −1.93, Group 3: −1.56%). The same is true of glucose (−1.00, −1.45, −1.48 mg/dl), TC (−1.08; 1.48; −1.20 mg/dl), LDL (−1.44, 1.82, 1, 27 mg/dl), TG (−1.08; −1.04; −1.04 mg/dl). HDL cholesterol increased in the 3 groups (+1.00, +1.17, +1.11).2: diabetes education and physical, exercise, 28Educational sessions with basic content on diabetes mellitus and 3--4 sections/week of aerobic exercise of moderate intensity with a duration of 60--90 min each.3: physical exercise, 263--4 sections/week of aerobic exercise of moderate intensity with duration of 60--90 min each.4: control, 27It was followed in normal diabetes consultations.Educational sessions, physical activity and dietary program: Asiatic continentAuthor referenceYear, countryGroup, number of patientsDescription of interventionLength of programResultsYuan et al.[@bib0795]2014, JapanIntervention, 448-week education on self-management of diabetes mellitus and subsequent 4 weeks of practice of the self-management guidelines3-monthHbA1c levels decreased in the intervention group and increased in the control group, *p* = 0.039/0.102, the same was found with fasting glucose, *p* = 0.238/0.427 and TG, *p* = 0.626/0.850. In both groups there was a decrease in TC, *p* = 0.034/\<0.001, LDL, *p* = 0.005/\<0.001). The HDL cholesterol increased in intervention group and decreased in the control group, *p* = 0.160/0.303).Control, 44Standard advice on medical nutrition therapy

Results and discussion {#sec0025}
======================

In the initial search were identified 230.825 studies through the PubMed/Medline database, of which 224.146 studies were excluded due to lack of relevancy and 6.679 were selected. Of these publications, 6.581 were excluded and 98 were initially selected based on title and abstract. Of these publications, 68 articles we excluded after full text reading; in the end 30 met the inclusion criteria and were considered for this systematic review. The flowchart for the selection of trials is shown in [Figure 2](#fig0005){ref-type="fig"}.Figure 2Flowchart depicting the study selection procedure.

Results of several studies confirm that physical exercise is a key tool in glycemic control and lipid profile in type 2 diabetic patients. The practice of physical activity programs is correlated with better glycemic control and lipid profile since it decreases glycated hemoglobin levels (HbA1c),[@bib0565], [@bib0710], [@bib0715], [@bib0720], [@bib0725], [@bib0730], [@bib0735], [@bib0740] fasting glucose[@bib0565], [@bib0710], [@bib0720], [@bib0730], [@bib0740], [@bib0745] and postprandial levels,[@bib0720] insulin resistance[@bib0720], [@bib0730], [@bib0740], [@bib0745] and fasting plasma insulin levels.[@bib0730], [@bib0740], [@bib0745], [@bib0750] It is also observed a decrease in TG,[@bib0565], [@bib0720], [@bib0730], [@bib0740], [@bib0755] TC,[@bib0565], [@bib0710], [@bib0720], [@bib0730], [@bib0735], [@bib0740] LDL,[@bib0565], [@bib0710], [@bib0730], [@bib0740] Apo B 48[@bib0755] an increase in HDL-cholesterol.[@bib0565], [@bib0710], [@bib0720], [@bib0730], [@bib0735]

Regarding the mode of exercise, it was found in three studies[@bib0715], [@bib0750], [@bib0755] that combined exercise, compared to individual aerobic or resistance exercise, has better benefits to people with diabetes. The intensity of the exercise influences the lipid profile because a moderate to low aerobic exercise does not reduce TG.[@bib0730]

In two studies[@bib0720], [@bib0740] it was found that aerobic resistance and flexibility exercise decreases HDL cholesterol. The fasting glucose increased in one study.[@bib0750]

In summary, with respect to changes caused by exercise in the different continents where the various studies were conducted it is demonstrated reduction of HbA1c, glucose, insulin, TG, TC, LDL cholesterol, Apo B 48, lower insulin resistance and HDL cholesterol increase. According with studies performed by Nojima et al.,[@bib0760] Kasumov et al.,[@bib0765] De Filippis et al.,[@bib0770] Lazarevic et al.[@bib0775] and Hordern et al.,[@bib0780] where it has also found that physical exercise is essential in the metabolic control of type 2 diabetes. The implementation of educational sessions that address the practice of physical activity and healthy eating were addressed in three of the studies analyzed. It can be seen that educational sessions that address the importance of physical activity and an healthy diet in diabetes control, in conjunction with aerobic exercise of moderate intensity, correlates with lower HbA1c,[@bib0785], [@bib0790], [@bib0795] glucose,[@bib0785], [@bib0790] TC, LDL cholesterol, TG and increased HDL cholesterol.[@bib0790], [@bib0795] Similar results were observed in a systematic review with meta-analysis performed by Steinsbekk et al. where the self-management education promotes better control of type 2 diabetes.[@bib0800]

A healthy and balanced nutrition is an essential component for the prevention and selfmanagement of type 2 diabetes.[@bib0485] A correct intake of the various food components, namely avoiding the excessive consumption of saturated fat and carbohydrates are important for obtaining a good glycemic and lipid control. A dietary program with emphasis on greater consumption of polyunsaturated fatty acids is correlated with lower levels of fasting glucose, TG, TC and LDL cholesterol.[@bib0805] This is in agreement with the results of the study of Lee et al.[@bib0810]

The intake of almonds reduces fasting blood glucose, HbA1c and increases fasting insulin. Regarding the lipid profile, there is an increase of TC and HDL cholesterol and a reduction of TG.[@bib0665]

The increased consumption of grains, fruit and vegetables alone (vegetarian diet) or in combination with supervised aerobic exercise correlates with decrease of HbA1c, glucose and fasting insulin, TG, TC and LDL. HDL cholesterol also decreases.[@bib0815] Given these results, the vegetarian diets may be beneficial for people with type 2 diabetes, as they induce glycemic and lipid control. However, we consider that is needed to be cautious in this matter as is also needed to carry out further studies in this field. According to the study of Takahashi et al., the consumption of vegetables is correlated with improved control of HbA1c and TG levels in elderly type 2 diabetes.[@bib0820] Modifying the amount of macronutrients may improve glycemic and lipid control in patients with type 2 diabetes. Low-calorie, low-fat and low-GI diets correlate with lower levels of HbA1c, fasting glucose and insulin, insulin resistance, TC, LDL and HDL cholesterol. TG had a slightly increase. When this type of diet is combined with physical activity, the results obtained are similar.[@bib0825] When uncontrolled type 2 diabetes ingest a low glycemic index liquid breakfast, rich in polyunsaturated fatty acids, fiber and fructose, reduces fasting glucose, TC, LDL, HDL cholesterol and increase the fasting insulin.[@bib0830] Since participants had uncontrolled DM2, replacement of breakfast alone as well as the intervention period may not have been sufficient to provide long term glycemic control. Thus, further investigations should be conducted in this population over a longer period of time, replacing not only breakfast but other meals. The consumption of low glycemic foods at breakfast decreased the HbA1c, glycated serum protein and insulin. There was an increase of glucose, insulin resistance, TG, TC, LDL, HDL cholesterol, Apo A1 and Apo B.[@bib0835] Results of the systematic review and meta-analysis of Ajala et al.[@bib0840] they demonstrated that low-carbohydrate, low glycemic index, Mediterranean, and high-protein diets are effective in controlling the glycemic and lipid profile and should be part of the management of type 2 diabetes.

The effectiveness of the consumption of chromium, vitamin D and probiotics supplements were also studied in some articles selected for this revision.[@bib0845], [@bib0850], [@bib0855], [@bib0860], [@bib0865], [@bib0870], [@bib0875], [@bib0880], [@bib0885], [@bib0890] The chromium supplementation for 3 months provides a reduction in HbA1c. And has also beneficial effects on dyslipidemia, since decrease TC, LDL cholesterol, VLDL cholesterol and TG levels, and increase HDL cholesterol.[@bib0845] The same is verified in a systematic review with meta-analysis performed by Suksomboon et al.[@bib0895]

Five of the studies analyzed the effectiveness of vitamin D supplementation in patients with type 2 diabetes.[@bib0850], [@bib0855], [@bib0860], [@bib0865], [@bib0870] The consumption of these supplements decrease the HbA1c,[@bib0850], [@bib0855], [@bib0860] glucose, insulin resistance[@bib0855] and increased insulin secretion.[@bib0860] Glucose increased in 3 studies,[@bib0860], [@bib0865], [@bib0870] such as HbA1c and insulin resistance.[@bib0865], [@bib0870] Given this, it can be seen that vitamin D supplementation provides a blood glucose control in the short and long term only in studies in the American and European continent. In Asia it was not found relation to benefits. This may be due to different lifestyles and eating habits of each region.

The lipid level results were not favorable because there was an increase in total cholesterol, LDL, HDL,[@bib0865], [@bib0870] TG increased in one study[@bib0870] in another decreased.[@bib0865] This discrepancy may be due to the fact that vitamin D administered was not the same in all studies, as well as the duration of treatment, of serum levels of vitamin D of the participants could be different, researchers may not have taken into account the sun exposure of the participants in the studies. Some scientific evidence has suggested that vitamin D may play a causal role in the development of diabetes and its complications. Deficiency of this vitamin is associated with increased risk of cardiovascular disease, obesity, diabetes mellitus, dyslipidemia and hypertension. High serum vitamin D concentrations have a protective effect on glucose intolerance, insulin resistance and the risk of developing DM2. The use of supplements of this vitamin in glycemic control, insulin resistance and lipid profile is not yet clear, although some studies have shown beneficial effects.[@bib0900], [@bib0905], [@bib0910], [@bib0915], [@bib0920], [@bib0925], [@bib0930], [@bib0935], [@bib0940], [@bib0945], [@bib0950], [@bib0955], [@bib0960] Four studies have analyzed the influence of the consumption of probiotics in patients with type 2 diabetes.[@bib0875], [@bib0890] It was found a decrease in glucose,[@bib0875], [@bib0880], [@bib0885] HbA1c,[@bib0880], [@bib0890] insulin[@bib0875], [@bib0890] and insulin resistance.[@bib0875], [@bib0885] Glucose and insulin resistance only increased in one study,[@bib0890] as well as HbA1c.[@bib0885] The consumption of probiotics in studies conducted in Asia translates into control of the short and long term blood sugar. On the European continent there was only a blood glucose control of short term and on the American continent the control was long-term.

There was a decrease in TC, LDL and TG in two studies,[@bib0880], [@bib0890] and increased in two other studies.[@bib0875], [@bib0885]The HDL cholesterol increased only in one study[@bib0875] and decreased in the remaining.[@bib0880], [@bib0885], [@bib0890] It may also be noted that only the administration of probiotics containing *Lactobacillus acidophilus* and *Bifidobacterium* provided lipid control. This discrepancy results may be due to five facts: the probiotic used, the amount administered, the time of administration, the duration of the treatment was not the same, as well as the continent where the studies were conducted (different dietary habits and lifestyles).

Since not all studies replicate positive results after taking vitamin D supplements and probiotics, the association between this supplementation and glycemic and lipid profile in type 2 diabetic elderly patients had a somewhat uncertain development. To provide more evidence is necessary to perform further studies to confirm the potentially beneficial relationship between supplementation with vitamin D and probiotics on glycemic and lipid profile in patients with type 2 diabetes.

Regarding the evaluation of the quality of the selected studies, as can be seen in the [Figure 1](#fig0010){ref-type="fig"}, it was found that most of the articles feature uncertain selection bias because they do not describe in detail the method used to generate the random sequence and to hide this sequence; half of the articles do not describe what measures used to blind outcome assessors in relation to knowledge of the intervention provided to each participant and the results according to what has been proposed. With regard to attrition and reporting bias, all studies are at low risk since all describe the sample size at the beginning and at the end of the study. If any participant was deleted or abandoned the study that fact is referenced as well the reasons for that.

Our study shows, however, some limitations that should be considered when interpreting the results, such as the intensity and type of exercise and different diet plans may affect the outcome; different duration of the programs, and the population studied in the various articles are also heterogeneous. The exercise and usual practice of physical activity and eating habits may be over underestimated, lack of monitoring of patients after program to evaluate the persistence of potential long-term benefits and unclear risk of bias in the included studies.

Another of the limitations is the fact that pharmacological treatment for diabetes is not taken into account as well as the use of dietary supplements or other treatments, particularly to lose weight. All this makes it difficult to compare the studies and their results.

Although, some articles do not show favorable results regarding the implementation of dietary programs, and prevails a greater number of articles that highlights the importance of nutrition education, physical activity and healthy eating on glycemic control and lipid profile in patients with type 2 diabetes. We understand therefore that it is appropriate to continue to perform this type of intervention, since they have lower cost if compared with pharmacological treatments, but in a longer period of time in order to prove the long-term results.

Conclusions {#sec0030}
===========

Given the high prevalence of type 2 diabetes in the population, particularly in the elderly population, and considering that this pathology tends to increase with age, it becomes crucial to change behaviors in activities of daily living, promoting more active and healthy lifestyles throughout life. Physical activity, dietary programs and health education sessions regarding the importance of changing lifestyles according to scientifically valid information are revealed as complementary therapeutic strategies in treatment and metabolic control of type 2 diabetes.
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